(Q45873752)

English

Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia

scientific article published on 14 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23680440

Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23680440

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

0 references

invasive disease

1 reference

based on heuristic

inferred from title

object named as

Eliana L Parra

1

0 references

author name string

Fernando De La Hoz

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23680440

Paula L Díaz

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23680440

Olga Sanabria

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23680440

María Elena Realpe

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23680440

Jaime Moreno

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23680440

language of work or name

0 references

publication date

14 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23680440

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23680440

31

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23680440

37

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23680440

4033-4038

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23680440

Streptococcus pneumoniae colonisation: the key to pneumococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae Serotype 20 strains: discovery of a new pneumococcal serotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Continued impact of pneumococcal conjugate vaccine on carriage in young children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigía Group, 1993 to 1999. PAHO Sireva-Vigía Study Group. Pan American Health Organization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countries.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Detection and serotyping of Streptococcus pneumoniae from nasopharyngeal samples by PCR-based multiplex assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Comparison of four polymerase chain reaction assays for specificity in the identification of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Prevalence of Streptococcus pneumoniae serotypes on nasopharyngeal colonization in children of Mexico City

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Serotypes of carriage and invasive isolates of Streptococcus pneumoniae in Brazilian children in the era of pneumococcal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

[Pneumococcal serotypes in carrier children prior to the introduction of anti-pneumococcal vaccines in Peru]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Changes in nasopharyngeal carriage and serotype distribution of antibiotic-resistant Streptococcus pneumoniae before and after the introduction of 7-valent pneumococcal conjugate vaccine in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Pre-vaccination nasopharyngeal pneumococcal carriage in a Nigerian population: epidemiology and population biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

A comparison of conventional and molecular microbiology in detecting differences in pneumococcal colonization in healthy children and children with upper respiratory illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization among Immunized and Unimmunized Children in a Community‐Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

[Streptococcus pneumoniae serotype replacement in nasopharyngeal colonization in children vaccinated with PCV7 in Mexico]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

The relationship between pneumococcal serotypes and antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.074

7 January 2021

Identifiers

10.1016/J.VACCINE.2013.04.074

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23680440

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23680440

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45873752&oldid=2087787081"